Meihua International Medical Technologies facilitates world’s second 5G remote robot-assisted lobectomy

image credit- shutterstock

Meihua International Medical Technologies, a manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its NT-2000 surgical path analysis system successfully supported the world's second 5G remote robot-assisted lobectomy. The procedure was performed at Yangzhou University Affiliated Hospital by a team from Shanghai Chest Hospital.

Mr. Yongjun Liu, Chairman of Meihua said, "Despite a physical distance of over 200 kilometers between the surgical team and the patient, the operation was executed seamlessly in just one hour, thanks to 5G technology and the precision of the robotic surgical system. We believe that robot-assisted surgery has made significant strides due to its clinical effectiveness, low risk, and quick recovery times. We also believe that successful implementations improve the quality of medical services, allowing patients to access diverse, personalized, and high-quality healthcare locally. We anticipate that this innovation will not only ease the workload on medical staff but also address disparities in medical resource distribution across China.”

The development of Meihua's robotic surgical systems is part of the Company's strategic initiatives to increase sales of high-end products and broaden its customer base. The Company has introduced new overseas technologies, including minimally invasive surgical robot systems, and established a dedicated research and development team focused on robotic-assisted surgery (RAS) systems. The Company believes its NT-2000 system's real-time monitoring and guidance capabilities enable precise targeting of surgical sites, improving the accuracy and success rates of operations. The RAS project is being developed in conjunction with the Hope City Medical Park in Hainan province, China. The project is expected to be completed in the fall of 2025.